Physician
Rcca MD LLC
Rcca MD LLC was paid $1.31M by Medicaid between Jan 2018 and Dec 2024, across 40 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 33% of everything it billed.
33Billing provider infoRCCA MD LLC
OLNEY, MD 20832
OLNEY, MD 20832
33aNPI1467800367assigned 06/01/2016
33bProvider typeHematology & Oncology Physician
28Total paid$1.31M
24GClaims47,432
24DCodes billed40
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Hematology & Oncology Physician providers in Maryland
Rank by total paid#4 of 30
Median peer was paid$116K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,102 | $284K | |
| 2019 | 13,023 | $367K | |
| 2020 | 6,755 | $272K | |
| 2021 | 5,372 | $171K | |
| 2022 | 5,034 | $110K | |
| 2023 | 3,646 | $93K | |
| 2024incomplete | 3,500 | $16K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 33% | 8,001 | 6,348 | $428K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 12% | 1,523 | 907 | $153K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 11% | 11,208 | 7,222 | $140K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 7.4% | 1,188 | 1,014 | $97K |
| 80053 | Comprehensive metabolic panel | 6.6% | 2,674 | 2,337 | $87K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 5.8% | 2,984 | 2,039 | $76K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 4.6% | 711 | 399 | $60K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.2% | 1,747 | 1,463 | $42K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 2.4% | 662 | 177 | $32K |
| 83615 | 2.2% | 833 | 771 | $29K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.1% | 859 | 572 | $27K |
| 99354 | 1.4% | 156 | 141 | $18K |
28 more codes
| J0897 | Injection, denosumab, 1 mg | 1.2% | 180 | $16K |
| 36415 | Collection of venous blood by venipuncture | 1.1% | 6,454 | $15K |
| 83550 | <1% | 982 | $13K | |
| 84100 | <1% | 229 | $8K | |
| 82378 | <1% | 355 | $8K | |
| 82728 | <1% | 787 | $7K | |
| 99205 | Prolong outpt/office vis | <1% | 55 | $7K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | <1% | 1,098 | $7K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 359 | $6K |
| 99223 | Prolong inpt eval add15 m | <1% | 51 | $5K |
| 96160 | <1% | 566 | $5K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 53 | $5K |
| 83540 | <1% | 995 | $4K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 84 | $4K |
| 96401 | <1% | 287 | $4K | |
| 96367 | <1% | 694 | $4K | |
| 82248 | <1% | 483 | $3K | |
| 99497 | <1% | 73 | $2K | |
| J1439 | Injection, ferric carboxymaltose, 1 mg | <1% | 107 | $839.82 |
| 82746 | <1% | 66 | $591.63 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 638 | $514.86 |
| 82607 | <1% | 54 | $428.91 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 12 | $348.72 |
| 90756 | <1% | 14 | $319.06 | |
| 82232 | <1% | 12 | $190.56 | |
| 86300 | <1% | 24 | $10.14 | |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 161 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJORDAN, TERRILL (PRESIDENT/CEO)
| Provider | Location | Paid |
|---|---|---|
| Regional Cancer Care Associates LLC | Toms River, NJ | $5.36M |
| Regional Cancer Care Associates LLC | Belleville, NJ | $1.06M |
| Regional Cancer Care Associates LLC | Manchester, CT | $686K |
| Regional Cancer Care Associates, L.L.C. | Washington, DC | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.